Table 2.
Mapping of drugs and drug classes in the OMOP reference set to ATC
| Aggregation | Drugs (ATC5) | Drug classes (ATC4) | ||
|---|---|---|---|---|
| Outcome | Positive | Negative | Positive | Negative |
| Acute kidney injury | 23 | 59 | 19 | 68 |
| Acute liver injury | 79 | 33 | 68 | 43 |
| Acute myocardial infarction | 33 | 61 | 18 | 72 |
| GI bleed | 24 | 62 | 19 | 73 |
| Total | 159 | 215 | 124 | 256 |
Positive and negative controls mapped to drugs and drug classes in ATC for the four adverse event outcomes in the OMOP reference set